Clearline Capital LP raised its holdings in Enfusion, Inc. (NYSE:ENFN – Free Report) by 33.8% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 245,145 shares of the company’s stock after acquiring an additional 61,971 shares during the quarter. Clearline Capital LP’s holdings in Enfusion were worth $2,326,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. RiverPark Advisors LLC acquired a new position in shares of Enfusion during the second quarter worth $68,000. Arizona State Retirement System acquired a new position in Enfusion during the 2nd quarter worth about $86,000. Price T Rowe Associates Inc. MD acquired a new position in Enfusion during the 1st quarter worth about $102,000. Harbor Capital Advisors Inc. grew its position in shares of Enfusion by 12.4% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock valued at $113,000 after buying an additional 1,315 shares during the last quarter. Finally, Belvedere Trading LLC acquired a new stake in shares of Enfusion in the third quarter valued at about $114,000. 81.05% of the stock is currently owned by institutional investors and hedge funds.
Enfusion Price Performance
Enfusion stock opened at $9.94 on Monday. The stock’s 50 day moving average is $9.32 and its 200 day moving average is $8.89. Enfusion, Inc. has a one year low of $7.52 and a one year high of $10.45. The firm has a market cap of $1.28 billion, a P/E ratio of 248.50, a P/E/G ratio of 3.72 and a beta of 0.93.
Enfusion Company Profile
Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.
Recommended Stories
- Five stocks we like better than Enfusion
- What is the Hang Seng index?
- Superstores to eCommerce Sales: Walmart Parties Like It’s 1999
- 3 Stocks to Consider Buying in October
- 3 Green Hydrogen Stocks That May Survive the Trump Chopping Block
- Transportation Stocks Investing
- Palo Alto Networks: A Pre-Split Investment Opportunity?
Want to see what other hedge funds are holding ENFN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enfusion, Inc. (NYSE:ENFN – Free Report).
Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.